Immuneering Corp Quarterly Operating Lease, Payments in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Immuneering Corp quarterly/annual Operating Lease, Payments history and growth rate from Q1 2021 to Q1 2024.
  • Immuneering Corp Operating Lease, Payments for the quarter ending March 31, 2024 was $193K, a 11.1% decline year-over-year.
  • Immuneering Corp annual Operating Lease, Payments for 2023 was $843K, a 38.3% increase from 2022.
  • Immuneering Corp annual Operating Lease, Payments for 2022 was $610K, a 447% increase from 2021.
  • Immuneering Corp annual Operating Lease, Payments for 2021 was $112K, a 90.1% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $193K -$24.1K -11.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 $217K +$52.7K +32.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $164K +$136K +492% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q1 2021 $27.7K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.